Inosita Plus XR 50mg/1000mg Tablets (14s)

Specification

Product Overview

Inosita Plus Xr 50mg 1000mg Tablets 14s by Pharmevo is a combination medication used to treat type 2 diabetes. It contains two active ingredients, Metformin Hcl and Sitagliptin, which work together to help control blood sugar levels.

Key Benefits

Dual action formula for effective diabetes management

- Helps lower blood sugar levels

- Supports weight loss in diabetic patients

- Improves insulin sensitivity

- Reduces the risk of cardiovascular diseases

How It Works

Metformin Hcl works by decreasing the amount of sugar produced by the liver and increasing the body's response to insulin. Sitagliptin works by increasing the levels of natural substances that lower blood sugar. Together, they help to regulate blood sugar levels in patients with type 2 diabetes.

Storage Instructions

Store this medication at room temperature away from light and moisture. Keep it out of reach of children and pets. Do not flush medications down the toilet or pour them into a drain unless instructed to do so.

Precautions

Precautions

Take this medication by mouth with food as directed by your doctor

- Swallow the tablet whole with a full glass of water

- Dosage is based on your medical condition and response to treatment

- Do not crush or chew the tablet

- Follow your doctor's instructions carefully

Before taking this medication, inform your doctor if you have kidney problems, liver disease, or heart failure

- Avoid alcohol while taking this medication as it can increase the risk of lactic acidosis

- Monitor your blood sugar levels regularly as directed by your doctor

- Report any symptoms of high or low blood sugar to your healthcare provider immediately

Additional Information

Manufacturer Information

Pharmevo is a trusted pharmaceutical company known for producing high-quality medications to improve patient health. With a commitment to innovation and excellence, Pharmevo aims to provide effective treatment options for various medical conditions.